UPDATE: Peregrine Pharma Reports Data on Bavituximab Presented at AACR Validates Immune-Stimulatory Mechanism of Action

By: via Benzinga
Peregrine Pharmaceuticals (NASDAQ: PPHM) today announced data from studies validating the immune-stimulatory mechanism of action of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.